IDEAYA Biosciences (IDYA) Current Leases (2019 - 2026)

IDEAYA Biosciences has disclosed Current Leases across 8 years of filings, most recently posting $350000.0 for Q1 2026.

• Current Leases for Q1 2026 came in at $350000.0, up 13.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $350000.0 (up 13.64% YoY), and the FY2025 annual result was $339000.0, up 13.76% from the prior year.
• Current Leases came in at $350000.0 for Q1 2026 at IDEAYA Biosciences, up from $339000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.1 million in Q3 2023 to a low of $298000.0 in Q4 2024.
• The 5-year median for Current Leases is $1.4 million (2022), against an average of $1.2 million.
• Across the five-year window, Current Leases increased 14.78% in 2023 and slumped 82.94% in 2024, its largest moves.
• IDEAYA Biosciences' Current Leases stood at $1.9 million in 2022, then decreased by 6.63% to $1.7 million in 2023, then plunged by 82.94% to $298000.0 in 2024, then gained by 13.76% to $339000.0 in 2025, then rose by 3.24% to $350000.0 in 2026.
• The last three Current Leases figures came in at $350000.0 (Q1 2026), $339000.0 (Q4 2025), and $328000.0 (Q3 2025), per Business Quant data.